Impel Pharmaceuticals
Karen Bodin-Rincon is a seasoned pharmaceutical professional with over 20 years of experience in specialty account management and neuroscience. Currently serving as Specialty Account Manager at Axsome Therapeutics, Inc. since October 2023, Karen has previously held positions as a Neuroscience Specialist at Impel NeuroPharma and Eisai US, and as a Senior Sales Representative at Takeda. With extensive DME experience and a strong background in promoting products across various specialties, Karen has demonstrated leadership through multiple awards and has held various leadership roles throughout a successful career. Karen is also committed to philanthropy, supporting organizations such as the Leukemia and Lymphoma Society and Make-A-Wish. Karen holds a Bachelor’s Degree in Speech-Language Pathology from the University of Louisiana at Lafayette.
This person is not in any offices
Impel Pharmaceuticals
Impel NeuroPharma, Inc., is a privately-held, Seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel's products are based on a novel nasal drug delivery platform, the POD™ device, that administers drug to the upper nasal cavity in a consistent and predictable manner.